Shenzhen Hepalink Pharmaceutical Group Co Ltd
SZSE:002399
Dividends
Dividend Yield
Shenzhen Hepalink Pharmaceutical Group Co Ltd
Current Yield | |
Min Yield | |
Max Yield | |
Average Yield | |
Median Yield |
Dividend Per Share
Shenzhen Hepalink Pharmaceutical Group Co Ltd
Payout Ratio
Shenzhen Hepalink Pharmaceutical Group Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Shenzhen Hepalink Pharmaceutical Group Co Ltd is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Shenzhen Hepalink Pharmaceutical Group Co Ltd
Average Annual Return | -13.69% |
Standard Deviation of Annual Returns | 10.12% |
Max Drawdown | -76% |
Market Capitalization | 16.1B CNY |
Shares Outstanding | 1 467 300 000 |
Percentage of Shares Shorted |
N/A
|
Stock Splits
Shenzhen Hepalink Pharmaceutical Group Co Ltd's latest stock split occurred on Jun 13, 2016
The company executed a 16-for-10 stock split, meaning that for every 10 shares held, investors received 16 new shares.
Before the split, Shenzhen Hepalink Pharmaceutical Group Co Ltd traded at 28.59 per share. Afterward, the share price was about 15.8569.
The adjusted shares began trading on Jun 13, 2016. This was Shenzhen Hepalink Pharmaceutical Group Co Ltd's 2nd stock split, following the previous one in Apr 29, 2011.